These chemicals represent a range of mechanisms that might indirectly influence SHOX2 activity, primarily through the modulation of gene expression, cell signaling pathways, and epigenetic modifications. The chemical class tentatively referred to as "SHOX2 Inhibitors" largely comprises compounds that interact with cellular pathways and processes related to gene expression regulation, cell differentiation, and development. Since SHOX2 is a transcription factor, direct inhibition is not straightforward, thus the focus is on indirect methods of modulation.
Compounds like DNA methyltransferase inhibitors (e.g., 5-Azacytidine, Decitabine) and histone deacetylase inhibitors (e.g., Vorinostat, Trichostatin A, Valproic Acid) can alter the epigenetic landscape, potentially impacting SHOX2 expression. Others, like Retinoic Acid, influence cell differentiation pathways, which could indirectly affect SHOX2's role. Additionally, inhibitors targeting various signaling pathways, such as Wnt (Lithium Chloride, Wnt-C59), mTOR (Rapamycin), MEK/ERK (PD98059), p38 MAPK (SB203580), and PI3K (LY294002), represent a strategy to modulate cellular environments and processes where SHOX2 plays a role.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that could alter the methylation status of the SHOX2 gene, potentially influencing its expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A histone deacetylase inhibitor that might affect chromatin structure and thereby regulate SHOX2 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Another histone deacetylase inhibitor, possibly altering SHOX2 expression by modifying chromatin accessibility. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
As a histone deacetylase inhibitor, it can influence gene expression, potentially including SHOX2. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor that may affect the methylation and expression of SHOX2. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Affects Wnt signaling pathway, which could indirectly modulate SHOX2 activity in developmental processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that might influence pathways involving SHOX2 during cell growth and differentiation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of the MEK/ERK pathway, potentially affecting pathways that regulate SHOX2 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that could alter signaling pathways involving SHOX2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, potentially affecting pathways that regulate SHOX2 activity. | ||||||